课题基金 / 基金详情

Neglected, preventable, and treatable: Integrating hepatitis B and syphilis into STBBI research among people who inject drugs

Neglected, preventable, and treatable: Integrating hepatitis B and syphilis into STBBI research among people who inject drugs
被忽视、可预防和可治疗：将乙型肝炎和梅毒纳入注射吸毒者的 STBBI 研究
批准号：
488759
负责人：
Larney Sarah
金额：
$7.28万
依托单位：
Centre hospitalier de l'Universit de Montral (CHUM)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2023
资助国家：
加拿大
项目状态：
已结题
起止时间：
2023-05-01 至 2024-05-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=488759&lang=en
关键词：
Acceptability Hepatitis B Virus People Who Inject Drugs Point-Of-Care Test Preferences Syphilis Vaccination

项目摘要

项目成果

Larney Sarah的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
People who inject drugs (PWID) are a key population for research on STBBIs. However, only HIV and hepatitis C virus have been well-studied in PWID. Two key neglected STBBIs in PWID are syphilis and hepatitis B virus (HBV). There are almost no data on the
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Increasing recruitment and retention of Anglophones to a prospective cohort of people who inject drugs in Montreal
Evaluation of supervised consumption services in Montreal in the context of COVID-19
Rapid review of the impacts of "Big Events" on people who use drugs and delivery of harm reduction and drug treatment services: Implications for strengthening systems in response to COVID-19
海外基金